During the past decade, Cancer and Leukemia Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer and Leukemia Center" #1 collaborator was "Cancer Commons" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cancer and Leukemia Center" are "BRAF Gene Mutation" (1 trials), "Bladder Cancer" (1 trials), "Cholangiocarcinoma" (1 trials), "Colorectal Cancer" (1 trials) and "ERK Mutation" (1 trials). Many other conditions were trialed in "Cancer and Leukemia Center" in a lesser frequency.

Most popular intervention types in "Cancer and Leukemia Center" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "NovoTTF-200T" (1 trials) and "Ulixertinib (BVD-523)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancer and Leukemia Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cancer and Leukemia Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Cancer and Leukemia Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cancer and Leukemia Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".